Pfizer Exercises Option for Tacere's Expressed RNAi HCV Drug

Tacere acquired the drug, dubbed TT-033, from Benitec in late 2006 after Benitec underwent a sweeping corporate reorganization that included the shuttering of its US operations.

Alnylam Receives Notice of Allowance for US Patent Application on RNAi Agents

According to the company, the application claims "certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates, for in vivo delivery."

Silence Therapeutics Issued Notice of Allowance for US Patent Application on Cancer Target

The target, PKN-3, is a protein kinase C-related molecule associated with the growth of cancer cells, as well as metastasis formation, and is the target for the company's phase I siRNA-based solid tumor drug Atu-027.

Stealth Spins Out miRNA-Inhibition Technology Into New Company

Concurrent with the move, the new company has also secured an undisclosed amount of seed financing that is expected to enable the new firm to complete planned in vivo proof-of-concept studies.

Asuragen Forms Collaborations to Develop FNA Version of Pancreatic Cancer miRNA Test

The test is expected to be available through Asuragen's clinical laboratory improvement amendments-certified lab in the second half of this year.

Benitec Continuation Patent Application Allowed by USPTO

The patent is derived from Benitec's key US patent, No. 6,573,099, which covers gene-expression knockdown using DNA that transcribes double-stranded RNA.

Papers of Note

RNAi- and microRNA-Related Papers Published January 2010

IP Update

USPTO Publishes Three Patents, Six Patent Applications Related to RNAi

People in the News

Palle Schelde, Thorlief Moller, John Riis Mortensen, Finn Cilius Nielsen, Ole Bitsch-Jensen, Daniel Kisner, Michael Forrest, Frank Karbe, Kenneth Galbraith, John Chiplin

Study Suggests MicroRNA, Tissue Evolution Closely Linked in Bilaterian Animals

Using small RNA sequencing, comparative genomics, and other approaches, German and American researchers found close ties between miRNA and tissue evolution in animals with bilateral symmetry.

From Genome Technology

Papers to Catch Up On

Articles appearing recently in peer-reviewed journals focused on Bayesian phylogenetics, bornavirus, and transmissible cancer in Tasmanian devils.

MicroRNAs for Risk Prediction

Genetic variation in the microRNA pathway may influence cancer risk, according to MD Anderson researchers studying patients who relapse.

Looking at the Host-Pathogen Connection

RNAi: Sumit Chanda

The MicroRNA Perspective

RNAi: Andrea Ventura